Day: December 11, 2024

FREMONT, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, today announced initial shipments of IQ8X™ Microinverters and IQ8P-3P™ Commercial Microinverters supplied from manufacturing facilities in the United States with higher domestic content than previous models. The microinverters have SKUs with a “DOM” suffix, indicating an increased amount of domestic content. Enphase announced in July 2024 that certain IQ8™ Microinverters, when paired with other U.S.-made solar equipment, could qualify for the domestic content bonus tax credit under the Inflation Reduction Act (IRA). Now, with the new IQ8 Microinverters having more components manufactured in the United...

Brings Significant Public Company Chief Executive Officer and Board Experience ANTIOCH, Tenn., Dec. 11, 2024 (GLOBE NEWSWIRE) — LKQ Corporation (Nasdaq: LKQ) (“LKQ” or the “Company”) today announced that it has appointed James S. Metcalf to its Board of Directors (the “Board”) as a new independent director effective December 11, 2024, as part of the Board’s ongoing refreshment process. The Company also announced that Dominick Zarcone has decided not to stand for re-election and will retire from the Board when his term expires in connection with the Company’s 2025 Annual Meeting. Following the 2025 Annual Meeting, the Board will consist of ten directors, nine of whom are independent. “Our Board is committed to active and ongoing refreshment to ensure it has the right mix of skills and experiences to provide effective oversight and...

DELAWARE, Ohio, Dec. 11, 2024 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, is hosting an Investor Day in New York City today, Wednesday, December 11, 2024, starting at 8:30 a.m. (ET). The event is expected to conclude at approximately 12:00 p.m. (ET). Ole Rosgaard, Chief Executive Officer, Larry Hilsheimer, Chief Financial Officer, and the Greif Executive Leadership Team will provide an in-depth review of the Company’s Build to Last strategy and future growth plans. “Our entire leadership team is excited to meet with investors for this in-depth strategic review.” said Ole Rosgaard, President and Chief Executive Officer. “We view our investors as key customers to us in our pursuit to being the best customer service company in the world. We are...

DANBURY, Conn., Dec. 11, 2024 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (NASDAQ: FCEL) — announced the upcoming release of its fourth quarter and fiscal year 2024 results prior to the Stock Market Open on Thursday, December 19, 2024. FuelCell Energy management will subsequently host a conference call with investors beginning at 10:00 a.m. Eastern Time on Thursday, December 19, 2024, to discuss the results and provide a business update. Participants can access the live call via webcast on the Company website or by telephone as follows:The live webcast of this call and supporting slide presentation will be available at www.fuelcellenergy.com. To listen to the call, select ‘Investors’ on the home page, proceed to the ‘Events & Presentations’ page and then click on the ‘Webcast’ link under the December 19th earnings call...

ATLANTA, Dec. 11, 2024 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NYSE: GTLS) (“Chart”), a global leader in clean energy and industrial gas solutions, today announced that its Board of Directors has authorized a share repurchase program of up to $250.0 million of its common stock. Under the stock repurchase program, Chart may purchase shares of its common stock through various means, including open market transactions, block purchases, privately negotiated transactions or otherwise in accordance with applicable federal securities laws, including Rule 10b-18 and Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The program may be modified, discontinued or suspended at any time without prior notice. We reiterate our financial policy of no share repurchases or material cash acquisitions until we are below 2.5 net leverage,...

EDISON, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (Nasdaq: HEPA) (the “Company” or “Hepion”), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, today announced that it has entered into a termination agreement with Pharma Two B Ltd. which terminates the merger agreement between the two parties that was previously entered into on July 19, 2024. Neither party will be required to pay the other a termination fee as a result of the mutual decision to terminate the agreement. Hepion also announced that its previously announced special meeting of its stockholders scheduled for December 12, 2024 has been cancelled and that it has withdrawn from consideration by its stockholders...

SCOTTSDALE, Ariz., Dec. 11, 2024 (GLOBE NEWSWIRE) — The Alkaline Water Company, Inc. (OTC: WTER), today issued an open letter from Ricky Wright, Chief Executive Officer, to shareholders discussing the Company’s progress to date with the advancement of the business model and the future plans for WTER. The full letter is published below: Dear Shareholders, I am excited to address our valued shareholders as I return to The Alkaline Water Company. From 2012 through 2022, we successfully established alkaline water as a recognized beverage category. Today, I am eager to share our path forward in this thriving billion-dollar market. The alkaline water market offers two distinct growth opportunities: pH-enhanced purified water and naturally alkaline spring waters. Both segments are experiencing strong consumer demand and remain highly...

Citizen Petition seeks correction of expiration date for New Chemical Entity (NCE) exclusivity on VOQUEZNA (vonoprazan) tablets Orange Book listings Phathom believes applicable law mandates a 10-year NCE exclusivity period (from date of first approval of drug containing vonoprazan) benefitting all vonoprazan-based products, with exclusivity until May 3, 2032FLORHAM PARK, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today it has submitted a Citizen Petition (CP) with the U.S. Food and Drug Administration (FDA). The petition formally requests correction of the Orange Book listings for VOQUEZNA (vonoprazan) 10 mg and 20 mg tablets to accurately reflect the full...